Funamizu, N.; Sakamoto, A.; Hikida, T.; Ito, C.; Shine, M.; Nishi, Y.; Uraoka, M.; Nagaoka, T.; Honjo, M.; Tamura, K.;
et al. C-Reactive Protein-to-Albumin Ratio to Predict Tolerability of S-1 as an Adjuvant Chemotherapy in Pancreatic Cancer. Cancers 2024, 16, 922.
https://doi.org/10.3390/cancers16050922
AMA Style
Funamizu N, Sakamoto A, Hikida T, Ito C, Shine M, Nishi Y, Uraoka M, Nagaoka T, Honjo M, Tamura K,
et al. C-Reactive Protein-to-Albumin Ratio to Predict Tolerability of S-1 as an Adjuvant Chemotherapy in Pancreatic Cancer. Cancers. 2024; 16(5):922.
https://doi.org/10.3390/cancers16050922
Chicago/Turabian Style
Funamizu, Naotake, Akimasa Sakamoto, Takahiro Hikida, Chihiro Ito, Mikiya Shine, Yusuke Nishi, Mio Uraoka, Tomoyuki Nagaoka, Masahiko Honjo, Kei Tamura,
and et al. 2024. "C-Reactive Protein-to-Albumin Ratio to Predict Tolerability of S-1 as an Adjuvant Chemotherapy in Pancreatic Cancer" Cancers 16, no. 5: 922.
https://doi.org/10.3390/cancers16050922
APA Style
Funamizu, N., Sakamoto, A., Hikida, T., Ito, C., Shine, M., Nishi, Y., Uraoka, M., Nagaoka, T., Honjo, M., Tamura, K., Sakamoto, K., Ogawa, K., & Takada, Y.
(2024). C-Reactive Protein-to-Albumin Ratio to Predict Tolerability of S-1 as an Adjuvant Chemotherapy in Pancreatic Cancer. Cancers, 16(5), 922.
https://doi.org/10.3390/cancers16050922
